Policy· August 25, 2026 · 15 min read
Wound PFDD Does Not Reset Skin-Substitute Pay; 351 BLAs Would Face Rebates
By Ran Chen#Medicare Part B#CMS#Drug Pricing
Topic
CMS
Centers for Medicare & Medicaid Services, Medicare and Medicaid policy, drug reimbursement, and federal healthcare program administration.
Policy· August 23, 2026 · 16 min read
CMS-10110 Turns Quarterly ASP Into a Part B MFP Compliance Feed: Comments Oct 20
By Ran Chen#CMS#ASP#Medicare Part B
Pricing & Access· August 22, 2026 · 17 min read
CMS's 340B OPPS Cut: ASP Minus 33.4%, the 2026 Survey, and August 31 Clock
By Ran Chen#340B#CMS#Medicare Part B
Pricing & Access· August 17, 2026 · 25 min read
Medicaid's September 10 Deadline: The Coverage Trade for GENEROUS Pricing
By Ran Chen#Medicaid#Drug Pricing#Payer Policy
Policy· August 9, 2026 · 18 min read
340B Rebate-Model Ruling: D.C. Circuit Puts HHS in the Driver's Seat (2026)
By Ran Chen#340B#Drug Pricing#Payer Policy
Policy· June 30, 2026 · 17 min read
IRA Medicare Drug Negotiation Proposed Rule: Market-Access Analysis
By Ran Chen#IRA Negotiation#CMS#Market Access
Policy· June 6, 2026 · 12 min read
Medicaid GLP-1 coverage state by state: the 2026 landscape
By Ran Chen#GLP-1#Medicaid#Payer Coverage
Pricing & Access· May 31, 2026 · 13 min read
Electronic prior authorization readiness for specialty drugs in 2027
By Ran Chen#Prior Authorization#CMS#Specialty Drugs
Pricing & Access· May 31, 2026 · 13 min read
FHIR prior authorization fields that cause specialty-drug denials
By Ran Chen#Prior Authorization#CMS#Specialty Drugs
Pricing & Access· May 27, 2026 · 11 min read